上海港灣(605598.SH)IPO定價為13.87元/股 推遲至9月8日進行申購
格隆匯8月16日丨上海港灣(605598.SH)發佈首次公開發行股票初步詢價結果及推遲發行公吿,根據初步詢價結果,綜合考慮發行人基本面、市場情況、所處行業、可比公司估值水平、募集資金需求及承銷風險等因素,協商確定此次發行價格為13.87元/股,網下發行不再進行累計投標詢價。
原定於2021年8月17日舉行的網上路演推遲至2021年9月7日,原定於2021年8月18日進行的網上、網下申購將推遲至2021年9月8日,並推遲刊登《上海港灣基礎建設(集團)股份有限公司首次公開發行股票發行公吿》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.